Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-275811.96%
↓ 3863% vs avg
Percentile
P0
Near historical low
Streak
1 qtr
Consecutive declineDecelerating
Average
-6959.62%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -275811.96% |
| Q3 2025 | -9.86% |
| Q2 2025 | -184.82% |
| Q1 2025 | 51.23% |
| Q4 2024 | -32.73% |
| Q3 2024 | 5.40% |
| Q2 2024 | -539.99% |
| Q1 2024 | 84.32% |
| Q4 2023 | -30.73% |
| Q3 2023 | 2.33% |
| Q2 2023 | -356.89% |
| Q1 2023 | 146.24% |
| Q4 2022 | -19.74% |
| Q3 2022 | 2.44% |
| Q2 2022 | -129.69% |
| Q1 2022 | 490.60% |
| Q4 2021 | -57.54% |
| Q3 2021 | 21.31% |
| Q2 2021 | -43.69% |
| Q1 2021 | 18.50% |
| Q4 2020 | -31.98% |
| Q3 2020 | -47.33% |
| Q2 2020 | -74.37% |
| Q1 2020 | 31.76% |
| Q4 2019 | -8.09% |
| Q3 2019 | 7.09% |
| Q2 2019 | -10.56% |
| Q1 2019 | 95.49% |
| Q4 2018 | -1039.08% |
| Q3 2018 | 15.28% |
| Q2 2018 | -2.43% |
| Q1 2018 | 89.65% |
| Q4 2017 | -986.10% |
| Q3 2017 | 13.60% |
| Q2 2017 | 20.69% |
| Q1 2017 | -8.10% |
| Q4 2016 | -71.47% |
| Q3 2016 | 48.64% |
| Q2 2016 | -16.28% |
| Q1 2016 | -15.87% |